Decreasing genomic sequencing costs and expanding clinical utilization of genomic data are transforming global disease risk profiling, rare disease diagnosis, and precision oncology. Detailed analysis within the human genetics Market report highlights how high-throughput next-generation sequencing (NGS), long-read sequencing, and microarray technologies are fueling clinical genomics research....